 2. Reproductive potential and agrees to follow one of the options listed below in the GlaxoSmithKline GSK modified list of highly effective methods for avoiding pregnancy in females of reproductive potential FRP requirements from 30 days prior to the first dose of study medication and until completion of the follow-up visit. 